药理学和上素抑制SETD2的趋同到基因组不稳定性
Alyssa T Paparella1, Ashley G Boice1, In Young Park1
1Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX 77030, USA.
Cancers
|March 14, 2026
概括
通过药理抑制或胆突变,SETD2 (组胺甲基转移酶) 的失活会导致基因组的不稳定. 这突出了SETD2的重要性.
科学领域:
- 表观遗传学和染色体生物学
- 癌症生物学和基因组学
- 分子瘤学分子瘤学
背景情况:
- SETD2 是一种关键的甲基转移酶,调节素H3 lysine 36甲基化 (H3K36me3) 和α-tubulin.
- 在瘤发生过程中失去SETD2功能会导致基因组不稳定性和癌症进展.
- 这项研究调查了基因组不稳定性是否是通过各种机制SETD2失活的一致结果.
研究的目的:
- 为了确定是否药理抑制或SETD2的科希斯介导的封存导致基因组不稳定.
- 阐明SETD2在维持不同细胞环境中的基因组稳定性中的作用.
- 探索针对癌症中SETD2的治疗影响.
主要方法:
- 使用了EPZ-719,一种SETD2抑制剂,以及一种H3.3K36M的胆固醇.
- 使用体外甲基化试验和西方分析对H3K36me3.3进行评估SETD2活性.
- 通过细胞遗传学分析量化了线粒体缺陷 (微核,染色体桥梁) 和动脉质.
主要成果:
- EPZ-719降低了SETD2活性,并增加了RPE-1和786-O细胞中的线粒异位缺陷 (染色体桥梁,微核).
- H3.3K36M 素表达降低了SETD2功能,在786-O细胞中诱导了线粒性缺陷,并在体细胞中引起了质积分.
- 联合抑制和胆激素表达并没有恶化缺陷,表明共享SETD2抑制机制.
结论:
- 通过药理学或胆激素机制抑制SETD2,始终会诱导线粒细胞缺陷和基因组不稳定.
- SETD2对于保持基因组稳定性至关重要,其无活化是正规特征.
- 向SETD2可能会在过度表达或胆固醇突变的癌症中产生治疗负债,可能导致癌症的进展.
相关概念视频
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
01:19Interactions Between Signaling Pathways
7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
02:36DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
02:36DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
01:10Drugs that Destabilize Microtubules
4.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K